Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets-Reference-Cited by-同舟云学术

Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets

Published:2023-12-27 Issue:1 Volume:50 Page:36-44
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Loke Ying Hui¹,Chew Yik-Ling²,Janakiraman Ashok Kumar²,Lee Siew-Keah³,Uddin A.B.M. Helal⁴,Goh Choon Fu⁵,Kee Phei Er⁶,Ng Hui Suan⁷,Ming Long Chiau⁸,Liew Kai Bin¹^ORCID

Affiliation:

1. Faculty of Pharmacy, University of Cyberjaya, Cyberjaya, Malaysia

2. Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia

3. M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang, Malaysia

4. Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia

5. School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

6. Centre for Research and Graduate Studies, University of Cyberjaya, Cyberjaya, Malaysia

7. UCSI-Cheras Low Carbon Innovation Hub Research Consortium, UCSI University, Cheras, Kuala Lumpur, Malaysia

8. School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia

Funder

University of Cyberjaya

University Research Grant Scheme

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2023.2294095

Reference38 articles.

1. Orally disintegrating tablets: an overview;Alǧin Yapar E.;J Appl Pharm Sci,2014

2. Orally disintegrating tablets: formulation, preparation techniques and evaluation;Nagar P;J Appl Pharm Sci,2011

3. Fast dissolving tablets: a review;Joshi R;Int J Pharm Sci Res,2020

4. Orodispersible tablets: an overview of formulation and technology;Gupta DK;World J Pharm Pharm Sci,2020

5. A study of the combination of microcrystalline cellulose and mannitol in a co-processed dry binder and in a physical mixture for the use in orally disintegrating tablets.